Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.
Pecho-Vrieseling E, Rieker C, Fuchs S, Bleckmann D, Esposito MS, Botta P, Goldstein C, Bernhard M, Galimberti I, Müller M, Lüthi A, Arber S, Bouwmeester T, van der Putten H, Di Giorgio FP. Pecho-Vrieseling E, et al. Among authors: bleckmann d. Nat Neurosci. 2014 Aug;17(8):1064-72. doi: 10.1038/nn.3761. Epub 2014 Jul 13. Nat Neurosci. 2014. PMID: 25017010
Author Correction: Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.
Pecho-Vrieseling E, Rieker C, Fuchs S, Bleckmann D, Esposito MS, Botta P, Goldstein C, Bernhard M, Galimberti I, Müller M, Lüthi A, Arber S, Bouwmeester T, van der Putten H, Di Giorgio FP. Pecho-Vrieseling E, et al. Among authors: bleckmann d. Nat Neurosci. 2018 Sep;21(9):1291. doi: 10.1038/s41593-018-0201-6. Nat Neurosci. 2018. PMID: 30018355
The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease.
Fox JH, Connor T, Chopra V, Dorsey K, Kama JA, Bleckmann D, Betschart C, Hoyer D, Frentzel S, Difiglia M, Paganetti P, Hersch SM. Fox JH, et al. Among authors: bleckmann d. Mol Neurodegener. 2010 Jun 22;5:26. doi: 10.1186/1750-1326-5-26. Mol Neurodegener. 2010. PMID: 20569486 Free PMC article.
Huntingtin cleavage product A forms in neurons and is reduced by gamma-secretase inhibitors.
Kegel KB, Sapp E, Alexander J, Reeves P, Bleckmann D, Sobin L, Masso N, Valencia A, Jeong H, Krainc D, Palacino J, Curtis D, Kuhn R, Betschart C, Sena-Esteves M, Aronin N, Paganetti P, Difiglia M. Kegel KB, et al. Among authors: bleckmann d. Mol Neurodegener. 2010 Dec 14;5:58. doi: 10.1186/1750-1326-5-58. Mol Neurodegener. 2010. PMID: 21156064 Free PMC article.
A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing.
Wehr C, Grotius K, Casadei S, Bleckmann D, Bode SFN, Frye BC, Seidl M, Gulsuner S, King MC, Percival MB, Pritchard CC, Walsh T, Wu D, Keel S, Salzer U. Wehr C, et al. Among authors: bleckmann d. Blood. 2018 Sep 13;132(11):1211-1215. doi: 10.1182/blood-2018-03-837336. Epub 2018 Jul 20. Blood. 2018. PMID: 30030275 Free PMC article. No abstract available.
12 results